SG11201607600TA - Vaginal composition and use thereof - Google Patents

Vaginal composition and use thereof

Info

Publication number
SG11201607600TA
SG11201607600TA SG11201607600TA SG11201607600TA SG11201607600TA SG 11201607600T A SG11201607600T A SG 11201607600TA SG 11201607600T A SG11201607600T A SG 11201607600TA SG 11201607600T A SG11201607600T A SG 11201607600TA SG 11201607600T A SG11201607600T A SG 11201607600TA
Authority
SG
Singapore
Prior art keywords
vaginal composition
vaginal
composition
Prior art date
Application number
SG11201607600TA
Other languages
English (en)
Inventor
Zhongming Zeng
Ruyun Zhou
Original Assignee
Singapore Ze&Z Internat Pte Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=54070942&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG11201607600T(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Singapore Ze&Z Internat Pte Ltd filed Critical Singapore Ze&Z Internat Pte Ltd
Publication of SG11201607600TA publication Critical patent/SG11201607600TA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
SG11201607600TA 2014-03-13 2015-03-11 Vaginal composition and use thereof SG11201607600TA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201410103662 2014-03-13
PCT/CN2015/073978 WO2015135470A1 (zh) 2014-03-13 2015-03-11 一种阴道用组合物与该组合物的用途

Publications (1)

Publication Number Publication Date
SG11201607600TA true SG11201607600TA (en) 2016-10-28

Family

ID=54070942

Family Applications (2)

Application Number Title Priority Date Filing Date
SG11201607600TA SG11201607600TA (en) 2014-03-13 2015-03-11 Vaginal composition and use thereof
SG10201807789WA SG10201807789WA (en) 2014-03-13 2015-03-11 Vaginal composition and use thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG10201807789WA SG10201807789WA (en) 2014-03-13 2015-03-11 Vaginal composition and use thereof

Country Status (7)

Country Link
US (2) US10869878B2 (zh)
EP (1) EP3117827B1 (zh)
CN (2) CN110840903B (zh)
CA (1) CA2942424C (zh)
MY (1) MY192494A (zh)
SG (2) SG11201607600TA (zh)
WO (1) WO2015135470A1 (zh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11166968B2 (en) 2015-09-29 2021-11-09 Kimberly-Clark Worldwide, Inc. Synergistic composition for maintenance of healthy balance of microflora
WO2017058174A1 (en) * 2015-09-29 2017-04-06 Kimberly-Clark Worldwide, Inc. Composition for maintaining loctobacillus dominance
EP3272333A1 (en) * 2016-07-22 2018-01-24 Chemo Research, S.L. Vaginal composition comprising a combination of estrogen and vitamin d
KR20190120235A (ko) 2017-02-28 2019-10-23 킴벌리-클라크 월드와이드, 인크. 미생물총의 건강한 균형을 유지하기 위한 상승적 조성물
CN109589404A (zh) * 2018-11-27 2019-04-09 杭州元研细胞生物科技有限公司 一种用于女性生殖系统抗衰修复产品及其制备方法
CA3167761A1 (en) * 2020-02-12 2021-08-19 Zhongming Zeng Bacteriostatic composition, preparation method therefor and use thereof
BR112023001039A2 (pt) * 2020-07-23 2023-03-28 Kimberly Clark Co Usos de composições para produzir medicamentos para modular um microbioma da bexiga e para prevenir ou tratar bexiga hiperativa, incontinência de urgência urinária ou infecções do trato urinário
CN112870335A (zh) * 2021-03-24 2021-06-01 广州修美生物科技有限公司 一种生物活性组合物及其应用以及利用该组合物制备得到的片剂
CN113308402A (zh) * 2021-05-25 2021-08-27 江苏恒康生物科技有限公司 一种缓解多激酶抑制剂副作用的益生菌高密度发酵组合物
WO2024026399A1 (en) * 2022-07-29 2024-02-01 Kimberly-Clark Worldwide, Inc. Methods and compositions related to prebiotic formulations useful in promoting urogenital health

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1390803A (en) * 1972-07-18 1975-04-16 Wootton L W Medicinal tampons and compositions containing lactulose
WO1999026636A1 (fr) * 1997-11-24 1999-06-03 Zhongming Zeng Formulation pharmaceutique de stimulation de la croissance de bacilles gram positifs et d'augmentation de l'acidite du vagin et leur utilisation
US6989163B2 (en) * 2001-10-23 2006-01-24 40 J's Llc Arrangement to enhance a woman's sexual sensitivity by a combination of phytoestrogens, L-arginine and menthol
US20060096587A1 (en) * 2003-03-24 2006-05-11 Cerestar Holding B.V. Comestibles containing isomaltulose and trehalose for sustained carbohydrate energy release and reduced glycemic/insulinemic responses, and for preserving osmolality
EP1462011A1 (en) 2003-03-24 2004-09-29 Cerestar Holding B.V. Comestibles containing Isomaltulose and Trehalose for sustained carbohydrate energy release and reduced glycemic/insulinimic responses
DE10349465B4 (de) * 2003-10-23 2014-04-03 Südzucker Aktiengesellschaft Mannheim/Ochsenfurt Gelatinefreie, Isomaltulose-haltige Weichkaramelle
ES2237732T3 (es) 2003-11-03 2005-08-01 Peter-Hansen Volkmann Composicion para el cuidado vaginal.
FR2874825B1 (fr) 2004-09-08 2006-12-08 Genibio Sarl Utilisations d'oligosaccharides prebiotiques benefiques pour la flore vaginale
SE528382C2 (sv) 2004-10-05 2006-10-31 Probi Ab Probiotiska lactobacillusstammar för förbättrad vaginal hälsa
EP1714660A1 (en) 2005-04-21 2006-10-25 N.V. Nutricia Uronic acid and probiotics
WO2006114061A1 (fr) * 2005-04-27 2006-11-02 Shenzhen Phlora Biotechnology Limited Composition et procédé de régulation et de maintien de la flore bactérienne vaginale et de l'acidité normale dans le vagin
WO2007085020A2 (en) * 2006-01-20 2007-07-26 Pear Tree Pharmaceuticals, Inc. Method of treating atrophic vaginitis
US8221774B2 (en) 2006-06-12 2012-07-17 The Procter & Gamble Company Lotioned wipe product to reduce adhesion of soils or exudates to the skin
US8980303B2 (en) * 2008-09-30 2015-03-17 Lugs International Ltd. Antimycotic and prebiotic pharmaceutical composition and a method for treating candidal vaginitis
IT1398279B1 (it) 2009-06-25 2013-02-22 Bsd Formulazioni farmaceutiche per uso intravaginale nella prevenzione e terapia delle vulvo vaginiti e nel ripristino della fisiologia vaginale
FI122247B (fi) 2009-08-12 2011-10-31 Vetcare Oy Probioottinen valmiste koiran maha- ja suolistokanavassa ilmenevien häiriöiden ennaltaehkäisemiseksi tai hoitamiseksi
EP2486922A4 (en) 2009-10-08 2013-05-29 Phlora Bio Technology Invest Ltd COMPOSITION COMPRISING BENZOIC ACID IN ASSOCIATION WITH ORGANIC ACID PRESERVATIVES AS ACTIVE COMPONENTS AND USE THEREOF
US8223571B2 (en) 2010-07-20 2012-07-17 Taiwan Semiconductor Manufacturing Company, Ltd. Generating and amplifying differential signals
DK2704704T3 (en) 2011-05-03 2019-01-14 Dupont Nutrition Biosci Aps PROBIOTIC BACTERIES FOR TOPICAL TREATMENT OF SKIN DISORDERS
CN102370598A (zh) 2011-09-30 2012-03-14 天津市中科健新材料技术有限公司 一种用于湿巾的益生元香体整理液
JP5927663B2 (ja) * 2011-10-21 2016-06-01 松谷化学工業株式会社 血糖値の上昇が緩やかな糖質組成物及び飲食品
SG11201402693VA (en) * 2011-11-30 2014-09-26 Meiji Co Ltd Nutritional composition for improving intestinal flora

Also Published As

Publication number Publication date
US20210077516A1 (en) 2021-03-18
CN110840903A (zh) 2020-02-28
US10869878B2 (en) 2020-12-22
SG10201807789WA (en) 2018-10-30
CA2942424A1 (en) 2015-09-17
EP3117827A4 (en) 2017-12-20
CN107073019A (zh) 2017-08-18
EP3117827A1 (en) 2017-01-18
US20160375045A1 (en) 2016-12-29
US11951116B2 (en) 2024-04-09
EP3117827B1 (en) 2021-11-03
WO2015135470A1 (zh) 2015-09-17
CA2942424C (en) 2019-12-31
MY192494A (en) 2022-08-24
CN107073019B (zh) 2020-04-17
CN110840903B (zh) 2021-08-31

Similar Documents

Publication Publication Date Title
GB201411197D0 (en) Composition and use thereof
IL247713A0 (en) Indazole 3-carboxyamides converted at the 5-position, their preparation and their use
HUE052359T2 (hu) Hidrofluorolefin-bázisú készítmény és alkalmazása
HK1231471A1 (zh) -雜芳氧基-和 芳氧基-喹啉- -甲酰胺及其用途
IL250568A0 (en) Anti-methanogenic preparations and their uses
HK1223969A1 (zh) 試劑盒及其用途
GB201401617D0 (en) Novel combination and use
HUE044571T2 (hu) Módosított ciklopentapeptidek és alkalmazásaik
HK1243950A1 (zh) 新型組合物和用途
SG11201607600TA (en) Vaginal composition and use thereof
PL3194656T3 (pl) Uchwyt listwy uszczelniającej oraz jego zastosowanie
SG11201608217PA (en) Fatty acid composition and use thereof
EP3008124A4 (en) STRENGTH COMPOSITIONS AND USE THEREOF
ZA201704105B (en) Refractories and use thereof
HK1243077A1 (zh) 呱啶基吡唑並嘧啶酮及其用途
GB201411196D0 (en) Composition and use thereof
IL251238B (en) Mineral-based compounds and their uses
PT3129398T (pt) Novos agentes médicos e usos dos mesmos
HK1231519A1 (zh) 試劑盒及其用途
DK3145548T3 (en) Aqueous gel composition and its use
GB2530711B (en) Security composition and use thereof
GB201420805D0 (en) Ligatures and use thereof
GB2545167B (en) Cloches and use thereof
PL3229772T3 (pl) 6-arylo-9-glikozylopuryny i ich zastosowanie
GB201500278D0 (en) Novel combination and use